BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28629884)

  • 1. [Evaluation of mortality after the analysis of the screening history in women diagnosed with infiltrating cervical cancer].
    Castillo M; Astudillo A; Clavero O; Velasco J; Ibáñez R; de Sanjosé S
    Aten Primaria; 2018 Mar; 50(3):151-158. PubMed ID: 28629884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.
    Castillo M; Astudillo A; Clavero O; Velasco J; Ibáñez R; de Sanjosé S
    PLoS One; 2016; 11(8):e0161403. PubMed ID: 27547971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?
    Jackson R; Wang L; Jembere N; Murphy J; Kupets R
    J Low Genit Tract Dis; 2019 Jan; 23(1):1-6. PubMed ID: 30489433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
    Lei J; Andrae B; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Wang J; Fang F; Dillner J; Elfström KM; Sparén P
    BMJ; 2019 Apr; 365():l1207. PubMed ID: 30944091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly women above screening age diagnosed with cervical cancer have a worse prognosis.
    Darlin L; Borgfeldt C; Widén E; Kannisto P
    Anticancer Res; 2014 Sep; 34(9):5147-51. PubMed ID: 25202106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-A national cohort study.
    Hammer A; Soegaard V; Maimburg RD; Blaakaer J
    Cancer Med; 2019 Jan; 8(1):418-427. PubMed ID: 30600650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underscreened Women Remain Overrepresented in the Pool of Cervical Cancer Cases in Spain: A Need to Rethink the Screening Interventions.
    Ibáñez R; Alejo M; Combalia N; Tarroch X; Autonell J; Codina L; Culubret M; Bosch FX; de Sanjosé S
    Biomed Res Int; 2015; 2015():605375. PubMed ID: 26180804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between cervical cancer screening and mortality from cervical cancer: a population based case-control study.
    Vicus D; Sutradhar R; Lu Y; Elit L; Kupets R; Paszat L;
    Gynecol Oncol; 2014 May; 133(2):167-71. PubMed ID: 24589414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
    Alves C; Alves L; Lunet N
    Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.
    Tranberg M; Larsen MB; Mikkelsen EM; Svanholm H; Andersen B
    BMC Public Health; 2015 Jul; 15():681. PubMed ID: 26194007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Australian National Cervical Screening Program in women of different ages.
    Smith M; Canfell K
    Med J Aust; 2016 Oct; 205(8):359-364. PubMed ID: 27736623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against squamous cell carcinoma and cervical adenocarcinoma afforded by cervical cytology screening: a cross-sectional study.
    Vale DB; Braganca JF; Morais SS; Zeferino LC
    Int J Gynecol Cancer; 2014 Feb; 24(2):321-8. PubMed ID: 24407579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. About invasive cervical cancer: a French population based study between 1998 and 2010.
    Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
    Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
    Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
    Morrell S; Taylor R; Wain G
    J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
    Mitchell H; Medley G; Giles G
    BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].
    Marquardt K; Stubbe M; Broschewitz U
    Pathologe; 2016 Feb; 37(1):78-83. PubMed ID: 26660458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Patterns of Cervical Cancer Screening Among Danish Women 55 Years and Older Diagnosed With Cervical Cancer.
    Hammer A; Hee L; Blaakær J; Gravitt P
    J Low Genit Tract Dis; 2018 Jan; 22(1):1-7. PubMed ID: 29271849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.